Filgrastim

This publication has 49 references indexed in Scilit:

• High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.
  Journal of Clinical Oncology, 1995
• Surveillance of Colony-Stimulating Factor use in us Academic Health Centers
  Annals of Pharmacotherapy, 1995
• Chemoprophylaxis with Oral Ciprofloxacin in Ovarian Cancer Patients Receiving Taxol
  Gynecologic Oncology, 1994
• The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma
  European Journal Of Cancer, 1994
• Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation.
  1994
• The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy
  European Journal Of Cancer, 1993
• Big Cost Savings from Small Filgrastim Unit Doses
  American Journal of Health-System Pharmacy, 1993
• Haematopoietic growth factors and cancer therapy.
  1993
• Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
  European Journal Of Cancer, 1993
• Dosage standardization for filgrastim
  American Journal of Health-System Pharmacy, 1992